Elbasha, Elamin; Chhatwal, Jagpreet; Ferrante, Shannon; … - In: Applied Health Economics and Health Policy 11 (2013) 1, pp. 65-78
Adding boceprevir to PR was projected to reduce the number of liver complications and liver-related deaths, and to be cost effective in treating both previously untreated and treated patients. </AbstractSection> Copyright Springer International Publishing Switzerland 2013
